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signaling. Our results suggest modulation of FHC or, cies (Curtin et al., 2002; Fleury et al., 2002). Another
more broadly, of iron metabolism as a potential ap- powerful strategy that cells have adopted to overcome
proach for anti-inflammatory therapy. ROS is to limit the cellular availability of transition met-
als, most notably iron. Indeed, this metal catalyzes the
Introduction generation of O2. in mitochondria and participates in
Fenton and Haber-Weiss reactions leading to formation
In addition to marshalling immune and inflammatory re- of ·OH (Curtin et al., 2002; Torti and Torti, 2002). This
sponses, NF-B transcription factors control apoptosis control of iron levels is achieved in part through metal
or programmed cell death (PCD) (Kucharczak et al., sequestration mediated by synthesis of ferritin—the ma-
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Table 1. Enrichment in ROS Regulators after Library Selection in relA/ Cells
Gene Name Msa No. SIE SIO SLRE/O Refs.
Apoptosis
FADD Msa.2049.0_at 210384.1 467.6 8.5 1 and 2
PPX Msa.17599.0_at 485121.4 3710.5 7.3 3–5
RelA Msa.1018.0_at 266918.6 3017.5 5.9 6 and 7
UFO/AXL receptor Msa.2518.0_at 222342 8597.2 4.9 8–10
ASM-1 Msa.2164.0_at 8781.1 443.6 4.2 11 and 12
Cathepsin L Msa.547.0_at 194898.7 12898.9 3.8 13–15
Cardiotrophin-1 Msa.1448.0_at 3476 285.9 3.7 16 and 17
Thymosin 4 Msa.1236.0_i_at 3787.5 273.8 3.7 18 and 19
VEGF Msa.1279.0_at 9045.7 994 3.3 20 and 21
c-Jun Msa.535.0_at 3485.1 281.4 3.1 22 and 23
PDGF receptor Msa.2594.0_at 3858.9 499 3 24 and 25
MDR-1 Msa.1675.0_at 16380.8 2773.1 2.7 26 and 27
1-AGP Msa.413.0_at 7281.7 1542.5 2.6 28
Krox-20 Msa.881.0_at 2324.1 425.9 2.6 29 and 30
GAPDH Msa.677.0_at 79463.6 17006.3 2.5 31 and 32
M-Twist Msa.1265.0_at 3353.2 581.5 2.5 33 and 34
HSP105 Msa.1937.0_at 6685.7 2656 2 35 and 36
c-MYC Msa.2088.0_at 2162.7 545.3 2 37 and 38
ROS and Iron Metabolism
Glutathione peroxidase-4 Msa.14493.0_at 10676.9 251.5 4.8 39
Uroporphyrinogen decarboxylase Msa.1781.0_at 6052.3 483.7 4 40 and 41
Heme oxygenase-1 Msa.1044.0_at 22789.5 3875.3 2.6 42 and 43
Ferritin heavy chain Msa.643.0_at 376017.5 67902.8 2.2 44 and 45
Cytochrome P-450IIIA Msa.2228.0_i_at 1342 434.9 1.8 46
(Catalase) Msa.505.0_at 1105 528.2 0.4 47
(Mn-superoxide dismutase) Msa.1633.0_at 1032.5 2618 1.3 48
(Ferritin light chain) Msa.644.0_l_at 1823.7 21797.3 3.2 44 and 45
Partial list of cDNAs enriched upon selection. Genes are grouped by function and ranked according to their SLR values. Msa No., Affymetrix
probe identification number; SIE and SIO, signal intensity values with probes prepared from enriched and original libraries, respectively; SLRE/O,
SLR of SIE versus SIO. Selected ROS scavengers that scored poorly (i.e., SLR 1) in the screen are in parentheses. Relevant references (Refs.)
are listed in the Supplemental Data.
genes that mediate the suppression of ROS by NF-B, activity of NF-B, we have employed the “death trap”
we performed a systematic screen of libraries enriched screen in relA/ cells (De Smaele et al., 2001; Vito et al.,
in antiapoptotic cDNAs using microarrays. Using this 1996). Expression libraries were transfected into these
approach, we identified ferritin heavy chain (FHC) as a cells by the use of the DEAE method, and apoptosis
pivotal mediator of the NF-B protective activity against was induced with TNF. Plasmids were then recovered
TNF-induced toxicity. FHC is one of two subunits of from surviving cells, and the resulting pooled cDNAs
ferritin, a heteropolymer that also consists of light chains were amplified in E. coli and used for subsequent rounds
(FLC) (Arosio and Levi, 2002; Torti and Torti, 2002). Un- of selection in relA/ cells, as described previously (De
like FLC, FHC exhibits ferroxidase activity—required for Smaele et al., 2001). This system previously yielded li-
iron sequestration (Arosio and Levi, 2002) —and is under braries highly enriched in antiapoptotic cDNAs, includ-
tight regulation by cytokines and oncogenes (Torti and ing those encoding RelA, the JNK pathway inhibitor
Torti, 2002). Here, we show that FHC, rapidly induced Gadd45, the catalytically inactive relative of caspase-8
by TNF in an NF-B-dependent manner, is essential c-FLIPL, and dominant-negative (DN) variants of the cas-
for suppressing TNF-induced killing and blocks PCD pase-8 activator FADD (De Smaele et al., 2001). Finally,
in NF-B/RelA null cells. The antiapoptotic activity of enrichment of antiapoptotic cDNAs was confirmed by
FHC functions to inhibit induction of ROS and, thereby, PCR, using libraries as templates and relA- or -actin-
activation of JNK by TNF. Together, these findings specific primers (data not shown).
establish a mechanism for NF-B-mediated control of To identify cDNAs that were enriched during selection,
ROS accumulation and apoptosis induced by TNF. The we utilized gene array technology. Original and selected
data also unravel a mechanism by which NF-B inhibits libraries were transcribed in vitro to generate cRNA
the JNK cascade. probes. These were then used to interrogate pairs of
Mu6500 microchips (Affymetrix)—which contain6,500
oligonucleotide sets derived mainly from known genes.Results
Putative antiapoptotic cDNAs were defined as those that
increased in frequency during selection and so yieldedSystematic Analysis of Genes Capable of Blocking
stronger hybridization signals with probes preparedPCD in relA/ Cells
from the enriched libraries than with probes preparedTo understand the mechanisms by which TNF induces
apoptosis and to define the basis for the protective from the original library. Since this approach required
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no information about gene sequence and/or function, it z-VADfmk (Figures 1E and 1F, respectively; see also Sup-
plemental Figure S1 on the Cell web site), indicatingoffered an unbiased method for isolating genes capable
of blocking apoptosis in NF-B null cells. that, in these cells, TNF induces death mainly through
an apoptotic mechanism. Indeed, TNF-R triggering in-This gene chip system also allowed clustering of iso-
lated genes based upon their putative function, thereby duced DNA fragmentation and caspase activation (Fig-
ures 1C–1F and Figure 4A; also data not shown)—twounmasking cellular defects caused by loss of NF-B.
Moreover, it enabled ranking of these genes according hallmarks of apoptosis (Danial and Korsmeyer, 2004).
Thus, although ROS can promote caspase-indepen-to their signal log ratio (SLR) score, which correlates
with the degree of enrichment during selection and so dent, necrosis-like death in some systems (Leist and
Jaattela, 2001), these species appear to induce deathprovides a semiquantitative indication of antiapoptotic
efficacy. Of the genes represented in the Mu6500 chip, by apoptosis in NF-B-deficient cells.
90 exhibited SLR values higher than 1 (data not shown).
These genes (or fragments of these genes) were there- FHC Is Transcriptionally Regulated by NF-B
fore those most highly enriched by selection, as deter- Since a deficiency in NF-B activity leads to apoptosis
mined by the use of this chip. Validating our approach, via ROS generation, we examined whether any of the
RelA and DN-FADD ranked eighth and second ac- ROS blockers isolated from our “death trap” screen (see
cording to this value (5.9 and 8.5, respectively; Table 1). Table 1) were subject to regulation by NF-B. As shown
in Figures 2A and 2B, fhc was induced rapidly by TNF
in control 3DO cells (Neo and parental, respectively)The Suppression of ROS Is a Protective
Mechanism Mediated by NF-B but not in 3DO cells expressing IBM. This induction
mirrored the expression of p50/p105 (data not shown),One group of genes enriched by selection with TNF
encoded factors previously associated with ROS metab- a known target of NF-B (Ghosh et al., 1998). fhc was
also upregulated by TNF in wild-type mouse embryonicolism and/or iron homeostasis (Table 1; Curtin et al.,
2002; Fleury et al., 2002). This finding suggests that fibroblasts (MEFs), and this upregulation was impaired
in RelA null cells (Figure 2C).defects in these metabolic systems contribute to the
susceptibility of RelA null cells to TNF-induced toxicity. Conversely, expression of other ROS modulators, in-
cluding gpx-1 and -4, cytochrome P-450III, and cyto-Therefore, we tested whether ablation of RelA affected
changes in redox status during TNF stimulation. In chrome oxidase I, as well as of thioredoxin, was unaf-
fected by either TNF or NF-B (Figure 2A and data notrelA/ cells transduced with empty MSCV vectors, ROS
progressively accumulated, beginning 2 hr after TNF shown). Heme oxygenase-1 (ho-1) was upregulated by
TNF but only at late times (Figure 2B and data nottreatment. In contrast, in cells transduced with MSCV-
RelA, TNF-induced ROS accumulation was markedly shown). Moreover, induction of ho-1 by PMA plus iono-
mycin (P/I) was independent of NF-B (Figure 2D). Mn2suppressed (Figure 1A). The antioxidant activity of RelA
was specific for TNF, as RelA expression did not affect superoxide dismutase (Mn-sod)—a ROS scavenger that
scored poorly in our screen (Table 1)—was upregulatedROS induction by antimycin A (Figure 1B)—a poison of
the mitochondrial respiratory chain (Chandel et al., by TNF in wild-type but not in relA/ MEFs (Figure
2C). However, in 3DO cells, Mn-sod was not induced by2001). Hence, the control of ROS induction by TNF-R
triggering is a physiologic function of NF-B. either TNF or P/I (Figures 2A, 2B, and 2D), indicating
that its expression is controlled by cell type-specificImportantly, control of ROS is crucial for NF-B to
suppress TNF-induced PCD. As shown in Figure 1C, mechanisms. Altogether, the data indicate that fhc is a
TNF-inducible gene and a downstream target of NF-pretreatment with the antioxidant, NAC, almost com-
pletely rescued relA/ fibroblasts from TNF-induced B. Conversely, other ROS blockers isolated from our
screen do not appear relevant to the antiapoptotic func-death in a dose-dependent manner. Similar findings
were obtained with PDTC—another blocker of ROS (Fig- tion of NF-B, and Mn-SOD may be relevant to this
function only in certain tissues.ure 1D). The protective effects of antioxidant agents
extended to other NF-B-deficient cell types. For exam- Because FHC is also subject to posttranscriptional
regulation (Torti and Torti, 2002), we sought to confirmple, 3DO T cell clones expressing IBM—an inhibitor
of NF-B—were highly sensitive to TNF-induced killing, the physiologic relevance of FHC induction by NF-B
by performing Western blots. As shown in Figure 2E,whereas control 3DO clones (Neo) were not (Figure 1F;
see also De Smaele et al. [2001]). The susceptibility of TNF failed to upregulate FHC in relA/ fibroblasts
transduced with empty MIGR1 vectors. This upregula-IBM-expressing cells to cytotoxicity by TNF was
blocked by antioxidant treatment, and protection af- tion was promptly restored upon complementation with
MIGR1-RelA. To further link FHC induction by TNF toforded by this treatment was virtually complete even at
late times (16 hr; compare survival of Neo and PDTC- NF-B, we used the HeLa-derived HtTA-RelA and HtTA-
p50 lines, where NF-B activation can be achieved bytreated, IBM clones; see also Supplemental Figure S1
at http://www.cell.com/cgi/content/full/119/4/529/DC1/ tetracycline withdrawal, independently of cellular stimu-
lation (Zong et al., 1999). As shown in Figure 2F, tetracy-). Similar protective effects of antioxidants have been
reported by others (Sakon et al., 2003). We concluded cline removal prompted upregulation of FHC in HtTA-
RelA cells but not in control HtTA-1 cells or HtTA-p50that NF-B blocks TNF-induced PCD, at least in part,
by upregulating genes that suppress production and/or cells, which conditionally express p50—a subunit of NF-
B that lacks activation domains (Ghosh et al., 1998).promote disposal of ROS.
In both relA/ fibroblasts and 3DO-IBM cells, TNF The FHC pattern of expression paralleled that of IB—
another target of NF-B (Ghosh et al., 1998). Hence,cytotoxicity was abrogated by the pancaspase inhibitor,
Cell
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Figure 1. The Suppression of ROS Is a Protective Mechanism Mediated by NF-B
(A) ROS induction by TNF in MSCV- and MSCV-RelA-transduced relA/ cells. Cells were treated with TNF (100 U/ml) plus CHX (0.1 g/ml),
and ROS levels were measured at the indicated times by spectrofluorometric analysis. Columns represent fluorescence units after subtraction
of the background values obtained with CHX-treated cultures and are the mean ( standard deviation) of three independent measurements.
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activation of NF-B/RelA is sufficient to upregulate FHC. despite normal activation of NF-B (data not shown).
Cytotoxicity correlated with the extent of FHC downreg-Altogether, the findings suggest that FHC induction by
TNF involves a transcriptional mechanism controlled ulation (data not shown). Confirming the specificity of
the observed effects, NIH-3T3 cells expressing controlby NF-B and underscore the importance of RelA in
this mechanism. siRNAs remained refractory to cytokine-induced PCD
(Figures 3E and 3F).
Of note, the effect of the fhc-198 siRNA on cell survivalFHC Is a Physiologic Blocker
of TNF-Induced Killing was comparable to that of relA-specific siRNAs (Supple-
mental Figure S3), which suggests that, in these cells,To ensure that induction of FHC by NF-B serves a
protective function, we monitored the effects of ectopic FHC is a dominant component of the antiapoptotic
mechanism activated by NF-B. Similar findings wereexpression of FHC on TNF-R-triggered PCD. Upon
transduction with MIGR1-FHC retroviruses expressing obtained with fhc- and relA-specific siRNAs in the HeLa-
derived line, HtTA-RelA (Supplemental Figures S4A andFLAG-tagged FHC, relA/ cells were markedly pro-
tected against TNF-induced death, whereas cells in- S4B), indicating that this dominance of the FHC protec-
tive activity against TNF-induced PCD extends to otherfected with empty MIGR1 were not (Figure 3A; see also
Supplemental Figure S2A, primary RelA null cells). As cell types and species (see Discussion). We concluded
that induction of FHC by NF-B is critically required toexpected, with MIGR1-RelA, rescue was complete (data
not shown). Resistance to apoptosis correlated with antagonize TNF-R-induced apoptosis and that defects
in this induction likely contribute to the propensity ofFHC levels (Figures 3B and 3C) and was nearly complete
at early times (Figure 3A, 8 hr), suggesting that FHC is relA/ cells to undergo PCD.
sufficient to temporarily suppress TNF-induced PCD.
Importantly, the FHC levels capable of affording near- FHC Inhibits Apoptosis Signaling
in NF-B Null Cellscomplete protection in relA/ cells (Figures 3A and 3B,
relative viral dose 1) approximate those achieved in wild- To understand how FHC confers protection from PCD
induced by TNF, we examined the effects of FHC ontype NIH-3T3 fibroblasts during stimulation with TNF
and found constitutively in certain primary tissues (e.g., caspase activation. In MIGR1-transduced relA/ fibro-
blasts, caspase-8 processing was detected as early asthe embryonic liver) and cell lines (Figure 3D and Supple-
mental Figure S2B, respectively; compare to MIGR1- 6 hr after treatment with TNF, with progressive proteol-
ysis of the proenzyme and accumulation of p41/p43FHC; note that, in Figure 3D, MIGR1-FHC expression is
similar to that of the highest viral dose in Figure 3C). In cleavage intermediates thereafter (Figure 4A). This coin-
cided with activation of the caspase-8 substrate Bid asfact, cytoprotection was dramatic even at lower FHC
levels (Figures 3B and 3C; see relative viral doses 1/2 well as of downstream procaspase-9 and -3 (Figure 4A,
MIGR1; see degradation of protein proforms and ap-and 1/4). In contrast, overexpressed Mn-SOD afforded
limited protection against PCD triggered by TNF (Fig- pearance of cleavage products). Proteolysis was spe-
cific, since control proteins such as -actin were notures 3B and 3C). These results, along with those from our
microchip screen (Table 1), show that FHC is a potent degraded in the cell extracts (Figure 4A) and coincided
with a marked increase in caspase-8, -9, and -3/-7 activi-blocker of TNF-induced apoptosis and a novel media-
tor of the protective function of NF-B. ties (data not shown). As expected, these events were
abrogated by expression of RelA (data not shown). Re-To further verify that physiologic levels of FHC were
cytoprotective, we used RNA interference (RNAi). In markably, TNF-induced caspase activation was also
suppressed by FLAG-FHC (Figure 4A). In MIGR1-FHC-NIH-3T3 fibroblasts, FHC was effectively knocked down
by expression of fhc-specific siRNAs, as shown by transduced relA/ cells, procaspases and Bid remained
virtually intact throughout stimulation with TNF, withWestern blots (Figure 3E, bottom; see fhc-198). Silenc-
ing was specific, since these siRNAs did not affect ex- modest accumulation of caspase-3 products seen only
at late times.pression of -actin or Lamin-A/C (Figure 3E and data
not shown). Furthermore, three different siRNA controls FHC also inhibited mitochondrial depolarization—
another key event in TNF-R-induced apoptosis (Danialhad no effect on FHC levels (Figure 3E; see also Supple-
mental Figure S3). Remarkably, FHC downregulation and Korsmeyer, 2004). In RelA null fibroblasts, the mito-
chondrial transmembrane potential began to drop 6 hrmarkedly increased susceptibility of NIH-3T3 cells to
TNF-induced killing (Figures 3E, top, and Figure 3F), after treatment with TNF, with60% of the cells exhib-
(B) ROS induction by a 2 hr treatment with antimycin A (1 g/ml). Cells and ROS measurements were as in (A). Shown are the values obtained
after subtraction of background from untreated cells.
(C) PI nuclear staining assays showing survival of relA/ cells after treatment with TNF (100 U/ml) plus CHX (0.1 g/ml), in the absence or
presence of a 1 hr pretreatment with the indicated concentrations of NAC. Values represent the percentages of live cells (i.e., with DNA
content 	N2) relative to cultures treated with CHX alone and are the mean  standard deviation of three independent experiments.
(D) PI nuclear staining assays showing survival of relA/ cells treated as in (C), in the absence or presence of a 1 hr pretreatment with the
indicated concentrations of PDTC. Values are the mean  standard deviation of three independent experiments and were calculated as in (C).
(E) PI nuclear staining showing survival of relA/ cells treated as in (C), in the absence (Ctrl.) or presence of a 1 hr pretreatment with z-VADfmk.
Values are the mean  standard deviation of three independent experiments and were calculated as in (C).
(F) PI nuclear staining assays showing survival of 3DO IBM clones after treatment with TNF (50 U/ml) in the presence or absence of a 1 hr
pretreatment with the indicated agents. Times and concentrations are shown. Neo control clones are in black. Values are the mean  standard
deviation of three independent experiments and were calculated as in (C).
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Figure 2. FHC Is a Physiological Target of NF-B
(A) Northern blots showing expression of ROS regulators in Neo and IBM 3DO clones treated with TNF (1,000 U/ml) for the times shown.
HO-1, heme oxygenase-1; Gpx, glutathione peroxidase; Cyt. Ox.-I, cytochrome oxidase subunit I; Cyt. P-450III, cytochrome P-450 IIIA.
(B) Northern blots showing expression of the indicated genes in parental 3DO cells treated as in (A).
(C) Northern blots showing expression of the indicated genes in early passage (p8) MEFs derived from twin relA/ and relA/ embryos and
treated with TNF (1000 U/ml).
(D) Northern blots showing expression of the indicated genes in parental and IBM 3DO cells treated with PMA (50 ng/ml) plus ionomycin
(1 M).
(E) Western blots showing induction of FHC in MIGR1- and MIGR1-RelA-transduced relA/ cells after cytotoxic treatment with TNF (1000
U/ml) plus low doses of CHX (0.1 g/ml). Exogenous RelA is shown.
(F) Western blots showing levels of the indicated proteins in the HtTA-RelA and HtTA-p50 lines and in control HtTA-1 cells following tetracycline
withdrawal. Induction of p50 and RelA transgenes was verified experimentally (data not shown).
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iting depolarized mitochondria by 12 hr (Figure 4B; ROS-Induced Cytotoxicity Is Mediated
by the JNK PathwayMIGR1). As expected, this drop was abrogated by com-
plementation with MIGR1-RelA (Supplemental Figure The NF-B-mediated control of TNF-induced PCD in-
volves suppression of JNK signaling (De Smaele et al.,S5). Depolarization was almost completely inhibited also
by FHC (Figure 4B; MIGR1-FHC). Thus, FHC blocks 2001; Javelaud and Besancon, 2001; Tang et al., 2001).
Thus, we examined whether inductions of JNK and ROSTNF-induced caspase activation and mitochondrial
depolarization in NF-B-deficient cells, thereby recapit- by TNF are linked or whether they represent indepen-
dent cytotoxic mechanisms. In RelA null fibroblasts,ulating the effects of NF-B on apoptosis pathways.
sustained JNK induction by TNF was almost com-
pletely blocked by treatment with NAC (Figure 6A),
whereas the acute phase of this induction was affectedFHC Prevents ROS Induction and Apoptosis
via Iron Sequestration only modestly by this treatment. Similar findings were
obtained with BHA, another antioxidant agent (data notThe observation that FHC protected NF-B null cells
from TNF-induced PCD prompted us to investigate shown). These effects of antioxidants on the JNK path-
way were confirmed in IBM 3DO clones (data notwhether FHC mediated the inhibition of ROS by NF-B
(Figure 1A). Remarkably, FHC suppressed ROS induc- shown), indicating that they extend to various cell types.
We concluded that ROS accumulation is required fortion in response to TNF in RelA null cells (Figure 5A;
MIGR1-FHC). To determine whether iron binding was persistent induction of JNK by TNF. Hence, in line with
data recently reported by others (Sakon et al., 2003),involved in this suppression, we then tested the effects
of FHC-222, a variant of FHC that lacks iron binding ROS lie upstream of JNK in the apoptotic cascade in-
duced by TNF-Rs.activity (Torti and Torti, 2002). As shown in Figure 5A,
expression of this mutant failed to block ROS accumula- Our findings predict that FHC inhibits JNK activa-
tion by TNF. To test this hypothesis, we monitoredtion induced by TNF, indicating that FHC-mediated
blockade of ROS requires iron sequestration. As seen TNF-induced JNK signaling in cells expressing FHC or
FHC-222 and in control cells. As shown previously, inwith RelA (Figures 1A and 1B), the inhibitory effects of
FHC were specific for the TNF pathway, as neither relA/ fibroblasts transduced with empty MIGR1 vec-
tors, activation of JNK signaling by TNF was rapid andmutant nor wild-type FHC affected ROS elevation fol-
lowing antimycin A treatment (Figure 5A). Hence, FHC remained sustained throughout stimulation (Figure 6B).
Similar effects were observed in MIGR1-FHC-222-trans-mimics the effects of NF-B on redox changes during
extracellular challenge. duced cells. Remarkably, however, upon expression of
FHC (MIGR1-FHC), JNK signaling returned to near-basalGiven the critical role of ROS in TNF-R apoptotic sig-
naling, we tested whether the protective activity of FHC levels by 30 min (Figure 6B). FHC also slightly affected
the acute phase of this signaling. Most importantly,also depended on iron binding. As shown in Figure 5B,
FHC-222 failed to inhibit TNF-induced killing in relA/ knockdown of FHC by siRNA in wild-type NIH-3T3 fibro-
blasts resulted in markedly increased JNK induction bycells. This lack of activity was not due to protein instabil-
ity or poor expression, as in these cells, FHC-222 levels TNF (Figure 6C). This exaggerated induction correlated
with the dramatic sensitivity of these cells to cytokine-were comparable to those of wild-type FHC (Figure 5B,
bottom). It has been proposed by others that, in certain induced cytotoxicity (Figures 3E and 3F and Supplemen-
tal Figure S3). Indeed, in fhc-198 siRNA-expressing fi-NF-B-proficient systems, FHC promotes survival by
mechanisms independent of its iron binding activity broblasts, kinetics of TNF-induced JNK activation were
reminiscent of those seen in NF-B-deficient cells (De(Cozzi et al., 2003). The nature of these mechanisms,
however, is unclear. Thus, to clarify this issue, we moni- Smaele et al., 2001). This suggests that FHC and NF-
B have similar effects on JNK activation in responsetored the effects of metal removal by means other than
FHC expression on cell survival. As shown in Figure to TNF. We concluded that FHC halts TNF-induced
killing, at least in part, by suppressing JNK activation5C, pretreatment with DFO—a well-characterized iron
chelator (Torti and Torti, 2002; see also Supplemental by ROS. These findings identify FHC as an indirect
mechanism by which NF-B controls the JNK cascade.Data)—dramatically inhibited TNF-induced PCD in
RelA null cells in a dose-dependent manner. Similar pro-
tective effects of DFO have been reported by others in Discussion
several additional mouse and human systems (Smirnov
et al., 1999; Brouard et al., 2000; Vulcano et al., 2000). We have identified FHC as a critical mediator of the NF-
Hence, iron plays a critical role in mediating TNF-R apo- B protective activity against TNF-induced cytotoxic-
ptotic signaling, and this appears to be the case in many ity. FHC is upregulated by TNF through a mechanism
tissues. Curiously, in the HeLa-derived clones used by that requires NF-B (Figures 2A, 2C, and 2E), is essential
Cozzi et al., iron inhibited rather than promoted TNF- to antagonize TNF-induced killing (Figures 3E and 3F
induced killing (Cozzi et al., 2003), which suggests that and Supplemental Figures S3, S4A, and S4B), and
these authors’ findings with FHC are due to an atypical blocks PCD in NF-B null cells (Figures 3A, 3B, 4A, 4B
behavior of iron in these clones. Altogether, the data and Supplemental Figures S2A). FHC-mediated sup-
indicate that the antioxidant activity of FHC involves iron pression of apoptosis involves inhibition of ROS accu-
sequestration and that this sequestration is crucial for mulation (Figures 5A and 5B), which in turn prevents
suppression of apoptosis induced by TNF. Indeed, the persistent activation of the JNK pathway (Figures 6A–
FHC-mediated blockade of ROS appears to be an es- 6C). These findings identify FHC as a critical effector
of NF-B-mediated suppression of ROS and define ansential component of the NF-B protective function.
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Figure 3. FHC Is a Physiologic Inhibitor of TNF-Induced Killing
(A) FHC blocks TNF-induced PCD in NF-B null cells. Survival of MIGR1- and MIGR1-FHC-transduced relA/ cells following treatment with
TNF (100 U/ml) plus CHX (0.1 g/ml). Shown are the percentages of live (i.e., adherent) GFP cells (determined by manual counting and
FCM) relative to the numbers observed in cultures treated with CHX alone. Values represent the mean  standard deviation of three
independent experiments.
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essential mechanism by which NF-B controls the JNK FHC expression effectively blocked TNF-induced
ROS accumulation and PCD in RelA null fibroblasts (Fig-cascade and, ultimately, apoptosis.
ures 3A, 3B, 5A, and 5B and Supplemental Figure S2A;
see also Figures 4A and 4B). Most importantly, silencingFHC as a Mediator of the NF-B
of FHC by siRNA in wild-type cells, which mimics theProtective Function
defective FHC expression seen in NF-B null cells, en-In agreement with our findings, another study has re-
hanced TNF-induced cytotoxicity (Figures 3E and 3Fcently implicated NF-B in the inhibition of ROS induc-
and Supplemental Figures S3, S4A, and S4B). In sometion by TNF (Sakon et al., 2003). The antioxidant activity
systems, fhc downregulation is sufficient on its own toof NF-B has been previously linked to upregulation of
induce death (Yang et al., 2002; Cozzi et al., 2004). TheMn-SOD (Bernard et al., 2001; Delhalle et al., 2002; Guo
biologic relevance of FHC is further underscored byet al., 2003), which catalyzes dismutation of O2. into
the findings that, in fibroblasts, fhc- and relA-specificH2O2 (Curtin et al., 2002). However, in various cells, Mn-
siRNAs have comparable effects on TNF-induced PCDSOD is induced by TNF only poorly or at late times
(Supplemental Figure S3) and that FHC levels capable(Delhalle et al., 2002; Guo et al., 2003)—well after the
of affording near-complete protection against this PCDonset of apoptosis. Moreover, in several NF-B null sys-
can be found under physiological conditions (Figurestems, Mn-SOD expression affords only little or no pro-
3A–3D and Supplemental Figure S2B). The early embry-tection against TNF-induced killing (Brouard et al.,
onic lethality of FHC knockout mice (Ferreira et al., 2000)2002; Delhalle et al., 2002; Sakon et al., 2003; see also
further supports the importance of FHC for cell survival.Figure 3B). Even in some wild-type systems, this factor
Indeed, the relevance of FHC for the NF-B-mediatedseems to be a poor blocker of TNF-induced PCD (Ber-
control of PCD extends to human cell systems and cellnard et al., 2001). Yet, despite the modest antiapoptotic
types other than fibroblasts (Supplemental Figure S4B).activity of overexpressed Mn-SOD, antioxidant treat-
Interestingly, downregulation of FHC expression is as-ment can effectively rescue NF-B null cells from death
sociated with a dramatic increase in intracellular ROS(Delhalle et al., 2002; Sakon et al., 2003; Figures 1C–1E).
levels (Kakhlon et al., 2001; Cozzi et al., 2004) and exag-We found that Mn-SOD expression does not correlate
gerated induction of JNK by TNF (Figure 6C). Altogether,with cytoresistance to TNF. In 3DO cells, this enzyme
these findings identify FHC as a dominant mediator ofwas not upregulated by TNF (or P/I), and its basal
the NF-B-protective activity against ROS-mediatedexpression was independent of NF-B (Figures 2A, 2B,
PCD and suggest that, at least in fibroblasts and HeLaand 2D). Furthermore, Mn-SOD exhibited weak protec-
cells, this factor is more relevant to this activity thantive activity in RelA null cells (Figure 3B; see also Sakon
previously described ROS scavengers.et al. [2003]). Consistently, Mn-SOD scored poorly in
our microchip screen (Table 1). Thus, in 3DO cells and
MEFs, this factor cannot be the sole effector of the ROS Inhibition in Cytoprotection
against TNF-Induced PCDantioxidant activity of NF-B.
In contrast, FHC was induced rapidly by TNF-R liga- ROS play an obligatory role in the induction of apoptosis
by TNF-Rs (Delhalle et al., 2002; Garg and Aggarwal,tion or P/I treatment, and this induction required NF-B
(Figures 2A–2D, Northern blots; see also Figures 2E and 2002; Matsuzawa et al., 2002; Sakon et al., 2003; also
Figures 1C, 1D, and 1F and Supplemental Figure S1).2F, Western blots). In HeLa cells, selective activation of
RelA was sufficient to upregulate FHC levels (Figure Following receptor triggering, ROS accumulation pre-
cedes caspase activation and mitochondrial depolariza-2F). Indeed, the fhc promoter contains putative NF-B
binding DNA elements (Torti and Torti, 2002). Other anti- tion (Figures 1A, 4A, 4B, and 5A), and inhibition of this
accumulation by various means blocks cytotoxicity (Fig-oxidant enzymes isolated from our screen do not appear
relevant to the NF-B-mediated control of apoptosis, as ures 1C, 1D, and 1F and Supplemental Figure S1; see
also Figures 3A, 3B, and 5A–5C; Delhalle et al., 2002;their expression was not modulated by TNF, and their
basal levels were independent of NF-B (Figures 2A, Garg and Aggarwal, 2002; Sakon et al., 2003). Proapo-
ptotic activity of ROS is mediated in part by the JNK2B, and 2D). Likewise, ho-1 was induced by TNF but
only at late times (Figures 2A and 2B)—well after activa- pathway (Garg and Aggarwal, 2002; Matsuzawa et al.,
2002; Sakon et al., 2003). Indeed, inhibition of the JNKtion of caspases (Figure 4A; De Smaele et al., 2001)—and
its activation by P/I did not require NF-B (Figure 2D). pathway represents a pivotal protective mechanism me-
(B) Unlike FHC, Mn-SOD exhibits only modest protective effects in NF-B-deficient cells. Survival of relA/ fibroblasts transduced with
standard (1) or partial (1/2 and 1/4) doses of MIGR1, MIGR1-Mn-SOD, or MIGR1-FHC retroviruses and treated as in (A). Values represent the
mean  standard deviation of two independent experiments and are calculated as in (A).
(C) Cytoprotection correlates with FHC levels. Western blots showing FLAG-FHC and FLAG-Mn-SOD expression in the relA/ cells used in
(B). Antibodies are indicated on the left-hand side.
(D) Western blots showing FHC expression in TNF-treated (1000 U/ml) NIH-3T3 fibroblasts and in MIGR1- and MIGR1-FHC-transduced
relA/ cells (3T3 KO). Equivalent amounts of extract (30 g) were loaded in each lane. Endogenous and exogenous FHC are shown. FLAG-
FHC levels are similar to those seen in (C), at relative viral dose 1 (data not shown).
(E) FHC is required to antagonize TNF-induced killing in fibroblasts. ELISA assays showing apoptosis in NIH-3T3 lines stably expressing
fhc-specific (fhc-198) or nonsilencing (mut-1, -2, and -3) siRNAs and treated for 9 hr with TNF (250 U/ml) or left untreated (top). Values are
expressed as arbitrary units and represent the mean  standard deviation of three independent experiments. Western blots showing FHC
and -actin levels in the same NIH-3T3 lines (bottom).
(F) Phase contrast images of NIH-3T3 lines treated as in (E) for 16 hr. A 10
 objective was used.
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Figure 4. FHC Blocks Apoptosis Signaling in NF-B Null Cells
(A) Western blots showing procaspase and Bid processing in MIGR1- and MIGR1-FHC-transduced relA/ cells after treatment with TNF
(100 U/ml) plus CHX (0.1 g/ml). Times, antibodies, cleavage products, and nonspecific (n.s.) bands are indicated. FLAG-FHC was detected
with an anti-FLAG antibody.
(B) Mitochondrial depolarization in MIGR1- and MIGR1-FHC-transduced relA/ fibroblasts treated as in (A). Values represent the percentages
of JC-1 cells relative to cultures treated with CHX alone and are the mean  standard deviation of three independent experiments.
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Figure 5. The FHC Inhibition of TNF-Induced ROS Accumulation and Apoptosis Involves Iron Sequestration
(A) ROS inhibition by FHC requires iron binding activity. ROS induction by antimycin A (1 g/ml) or TNF (100 U/ml) plus CHX (0.1 g/ml) in
MIGR1-GFP-, MIGR-GFP-FHC-, and MIGR1-GFP-FHC-222-transduced relA/ cells. ROS measurements and value calculations were
performed as in Figure 1A. Shown are the means ( standard deviations) of three independent measurements.
(B) Iron binding is essential for the FHC suppression of TNF-induced PCD. Survival of MIGR1-, MIGR1-FHC-, and MIGR1-FHC-222-transduced
relA/ cells after a 9 hr treatment with TNF (100 U/ml) plus CHX (0.1 g/ml) (top). Percentages of live GFP cells were determined as in
Figure 3A. Shown are the means  standard deviations of three independent experiments. Western blots showing levels of -actin, FLAG-
FHC, and FLAG-FHC-222 (bottom and middle).
(C) Iron depletion protects NF-B-deficient cells from TNF-induced killing. PI nuclear staining showing survival of relA/ cells treated with
TNF plus CHX as in (B) in the presence or absence of a 1 hr pretreatment with the indicated concentrations of DFO. Values were calculated
as in Figure 1C and represent the means  standard deviations of three independent experiments.
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Figure 6. FHC Prevents Sustained JNK Induction by TNF in NF-B-Deficient Cells
(A) ROS are required for prolonged JNK activation by TNF. Kinase assays (K.A.) showing JNK induction by TNF (1000 U/ml) in relA/ cells,
in the presence or absence of a 20 min pretreatment with NAC (20 mM) (top). Western blots showing total JNK levels (bottom).
(B) FHC inhibits JNK induction by TNF, and this activity involves iron sequestration. Kinase assays showing kinetics of JNK induction in
MIGR1-, MIGR-FHC-, and MIGR1-FHC-222-transduced relA/ cells treated with TNF as in (A) (top). Western blots showing total JNK
levels (bottom).
(C) FHC is required for downmodulation of TNF-induced JNK signaling. Kinase assays showing JNK activation in NIH-3T3 lines expressing
fhc-specific or nonsilencing (mut-1) siRNAs and treated with TNF as in (A) (top). Western blots showing total JNK levels (bottom). FHC
expression is shown in Figure 3E.
diated by NF-B (De Smaele et al., 2001; Javelaud and shown that suppression of JNK signaling by NF-B in-
volves induction of Gadd45 (De Smaele et al., 2001).Besancon, 2001; Tang et al., 2001), and knockdown of
the JNK kinase MKK7/JNKK2 rescues RelA null cells However, this induction cannot explain the effects of
NF-B on redox metabolism (Sakon et al., 2003; Figurefrom TNF-induced killing (Deng et al., 2003). Notably,
the relevance of the crosstalk between NF-B and JNK 1A). Thus, we propose that NF-B halts the JNK cascade
via at least two distinct mechanisms: directly, throughto cell survival has been documented in animal models
by using JNK knockout systems (Maeda et al., 2003). Gadd45-mediated blockade of MKK7 (Papa et al.,
Our data support a model whereby NF-B activation 2004), and indirectly, through FHC, which blunts ROS
upregulates expression of FHC, which sequesters free production. To ensure effective inhibition of JNK signal-
iron, and so blunts ROS production, sustained JNK sig- ing, Gadd45 and FHC likely act in concert. Indeed,
naling, and, ultimately, apoptosis triggered by TNF. kinetics of induction suggest that transient activation of
Gadd45 may provide acute protection against TNF-
induced toxicity and that sustained FHC upregulationThe Suppression of JNK Signaling by NF-B
Our findings identify FHC as an additional link between serves to secure long-term survival. FHC may also coop-
erate with Mn-SOD. It is conceivable that, while upregu-the NF-B and JNK pathways. Previously, we have
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BsrG1 and destroyed NotI sites are italicized; internal SfiI, XhoI,lation of Mn-SOD promotes O2. dismutation into H2O2
BspHI, and NotI sites are underlined). For cDNA synthesis, poly-A(Curtin et al., 2002), FHC-mediated iron depletion allows
mRNA was isolated from NIH-3T3 cells treated with TNF (1000disposal of H2O2 by catalases and peroxidases, thereby U/ml) for 2.5 or 5.5 hr, and reverse transcriptase (RT) reaction was
preventing formation of highly reactive ·OH radicals set up using pooled mRNA samples, an oligo(dT) primer (containing
(Torti and Torti, 2002). Indeed, residual availability of a NotI site), and the Superscript II kit (Invitrogen, Carlsbad, CA),
according to manufacturer’s instructions. Upon size fractionation,iron, resulting from FHC deficiency, may explain why
the cDNA was ligated to SfiI adaptors (sense, 5-GAAGCCCTCG-Mn-SOD alone is unable to effectively suppress TNF-
3; anti-sense, 5-GGGCTTC-3), digested with NotI, and cloned di-induced PCD in NF-B null cells (Figure 3B; Brouard et
rectionally into the NotI and SfiI sites of pLTP-GFP. This libraryal., 2002; Delhalle et al., 2002; Sakon et al., 2003). While
yielded 1.8 
 106 independent clones, had an average insert size
not sufficient, however, Mn-SOD might still be needed of 1.7 kb, and expressed polypeptides fused to enhanced green
for the NF-B antiapoptotic function in some biologi- fluorescent protein (eGFP).
Library selection was carried out essentially as described pre-cal contexts.
viously (De Smaele et al., 2001). Briefly, 4 
 106 independent library
clones were transfected into relA/ 3T3 cells by using the DEAE
Relevance to Chronic Inflammation and Cancer method. Twenty-four hours later, cells were subjected to a 21 hr
Notably, the protective effects of FHC likely extend be- treatment with TNF (150 U/ml) plus cycloheximide (CHX; 0.1g/ml).
Detached cells were then washed away, and adherent (live) cellsyond the cellular level and may, in fact, mediate a sys-
were trypsinized, purified with Lympholyte Ficoll (Accurate Chemicaltemic defense mechanism activated by NF-B. FHC is
and Scientific Corp., Westbury, NY), and resuspended in lysis solu-a component of the organismal acute phase response
tion (0.6% SDS and 10 mM EDTA) for extraction of episomal DNA.
to stress, injury, and infection (Torti and Torti, 2002; The library was finally electroporated into ElectroMax DH10B E. coli
Weiss, 2002). Proinflammatory cytokines such as TNF (Invitrogen, Carlsbad, CA), amplified, and used for another cycle of
profoundly impact iron metabolism, and induction of selection in relA/ cells.
FHC synthesis in the liver appears to be a major cause of
cRNA Probe Preparation and Microarray Analyseshypoferraemia and anemia during chronic inflammation
To generate biotinylated cRNA probes, original and selected librar-(Torti and Torti, 2002; Weiss, 2002). Thus, generalized
ies were treated with RNase and Proteinase K in 0.5% SDS, digested
restriction of metal availability may enable NF-B to with BsrGI, and subjected to in vitro transcription (IVT) using the
contain cytokine-induced injury at distant sites, such SP6 RNA polymerase MEGAscript kit (Ambion Inc., Austin, TX) and
as, for instance, at sites of inflammation, where there biotinylated UTP and CTP (Enzo Diagnostic, Farmingdale, NY).
Probe hybridizations to Mu6500 oligonucleotide microarrays (repre-are high levels of TNF and oxygen radicals. Consistent
senting 6,500 murine genes; Affymetrix, Santa Clara, CA) werewith this notion, systemic iron depletion by DFO mark-
performed according to standard procedures at Research Geneticsedly protects mice from TNF-R-mediated tissue damage
(Huntsville, AL). Comparative analyses of signal intensities (SI) were
and lethality (Vulcano et al., 2000). carried out using the Affymetrix Microarray Suite 5.0 (MAS v5.0) with
FHC also plays an important role in cancer (Torti and default analytic parameters, and genes were ranked according to
Torti, 2002). During malignant transformation, FHC ex- their SLR value (as defined in the Affymetrix Statistical Algorithms
Description Document). This value represents the change in SI forpression is repressed by oncogenes such as c-Myc and
a cDNA between original (baseline) and selected libraries and isadenovirus E1A (Arosio and Levi, 2002; Torti and Torti,
expressed as log2 ratio.2002). This repression is associated with an increase in
intracellular free iron and ROS levels (Benhar et al., 2002; ROS Measurements
Cozzi et al., 2004; Kakhlon et al., 2001; Tanaka et al., Dichlorodihydrofluorescein diacetate (H2DCFDA) was from Molecu-
2002; Torti and Torti, 2002), which promote apoptosis, lar Probes (Eugene, OR). Intracellular ROS levels were measured as
described elsewhere (Chandel et al., 2001). Briefly, 30 min prior toboth under basal conditions and upon treatment with
adding TNF or antimycin A, cultures were treated with 25 Mchemotherapeutic drugs (Benhar et al., 2002). In the
H2DCFDA in phenol red-free and serum-free DMEM. At the timesearly stages of cancer, this elevation of ROS (and JNK
indicated, cells were lysed in luciferase buffer (Chandel et al., 2001),
activity) appears to be critical for proliferation and main- and H2DCFDA oxidation into 2,7 dichlorofluorescein (DCF) was
tenance of a transformed phenotype (Benhar et al., measured by spectrofluorometric analysis at 485 nm (excitation)
2002). With tumor progression, however, growth be- and 528 nm (emission) using a FLx 800 reader (Bio-Tek Instruments,
Inc., Winooski, VT). Further information regarding DFO and H2DCFDAcomes independent of ROS (Benhar et al., 2002), which
and their applications can be found in the Supplemental Data.allows cancer cells to upregulate FHC, thereby promot-
ing tumor resistance to anticancer agents (Torti and
Additional Methods
Torti, 2002). Indeed, the protective activity of FHC ex- Information on additional methods, plasmids, cells, and reagents
tends to oxidative and genotoxic stress (Arosio and Levi, can be found in the Supplemental Data.
2002; Torti and Torti, 2002), and high FHC levels have
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